Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Bevilacqua

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
JAMA Dermatology|September 11, 2024
Cord Blood Serum Levels of IL-31 and CCL17, Cutaneous Markers, and Development of Atopic DermatitisAngelo Massimiliano D'Erme, Cristian Fidanzi, Matteo Bevilacqua, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|January 9, 2025
Correlation between skin cancer and therapy with anti-IL monoclonal antibodies in patients affected by moderate-to-severe psoriasis: an observational monocentric studyFlavia Manzo Margiotta, Cristian Fidanzi, Simone Pardossi, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
JAMA Dermatology|September 11, 2024
Cord Blood Serum Levels of IL-31 and CCL17, Cutaneous Markers, and Development of Atopic DermatitisAngelo Massimiliano D'Erme, Cristian Fidanzi, Matteo Bevilacqua, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|January 9, 2025
Correlation between skin cancer and therapy with anti-IL monoclonal antibodies in patients affected by moderate-to-severe psoriasis: an observational monocentric studyFlavia Manzo Margiotta, Cristian Fidanzi, Simone Pardossi, et al.
Pageof 4